Vet survey shows outlook is better - Morgan Stanley
Tweet
Share
E-mailGet Alerts ZTS Hot Sheet
Price: $75.35 +0.69%
Rating Summary:
18 Buy, 15 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
18 Buy, 15 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
Morgan Stanley analyst Erin Wright notes a proprietary AlphaWise US vet survey points to sequentially lighter 1Q demand, but they are encouraged the NTM and next quarter's outlook are trending upward.
The firm favors Zoetis (NYSE: ZTS) and IDEXX Labs (NASDAQ: IDXX) into earnings, despite the recent moves higher in the stocks.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bicara Therapeutics Inc (BCAX) PT Raised to $39 at BTIG
- Owlet (OWLT) Tops Q2 EPS by 9c
- Canterbury Park (CPHC) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Morgan Stanley, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
